Lucid Diagnostics Inc.
LUCD
$1.39
$0.118.59%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -12.37M | -11.01M | -10.61M | -10.83M | -14.21M |
Total Depreciation and Amortization | 215.00K | 229.00K | 501.00K | 629.00K | 625.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 2.12M | 1.21M | 831.00K | 423.00K | 4.30M |
Change in Net Operating Assets | -139.00K | -1.91M | -3.33M | -201.00K | 503.00K |
Cash from Operations | -10.18M | -11.48M | -12.61M | -9.98M | -8.78M |
Capital Expenditure | 0.00 | 0.00 | -37.00K | -175.00K | -14.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -350.00K | -- | -- | -- | -- |
Cash from Investing | -350.00K | 0.00 | -37.00K | -175.00K | -14.00K |
Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 94.00K | 0.00 | 357.00K | 0.00 | 275.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | 0.00 | 11.63M | 18.17M | 5.00M | 0.00 |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 94.00K | 11.63M | 18.52M | 5.00M | 275.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -10.43M | 151.00K | 5.87M | -5.15M | -8.52M |